Richard A. Paulson - 05 Sep 2023 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
President and CEO, Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Richard Paulson
Issuer symbol
KPTI
Transactions as of
05 Sep 2023
Net transactions value
-$4,817
Form type
4
Filing time
06 Sep 2023, 16:06:34 UTC
Previous filing
08 Aug 2023
Next filing
05 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $4,732 -3,558 -0.44% $1.33 798,460 05 Sep 2023 Direct F1
transaction KPTI Common Stock Sale $84.48 -64 -0.01% $1.32 798,396 05 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.